Category: General Biotechnology

New patent expiration for Astrazeneca drug SYMBICORT

   July 29, 2023    Comments Off on New patent expiration for Astrazeneca drug SYMBICORT    Posted in: General Biotechnology

Annual Drug Patent Expirations for SYMBICORT Symbicort is a drug marketed by Astrazeneca and is included in one NDA. It is available from three suppliers. There are eleven patents protecting…
The post New patent expiration for Astrazeneca drug SYMBICOR…

Continue reading

New tentative approval for Mylan Labs drug posaconazole

   July 6, 2023    Comments Off on New tentative approval for Mylan Labs drug posaconazole    Posted in: General Biotechnology

[![posaconazole structure](https://www.DrugPatentWatch.com/img/drug-structure/posaconazole.png)](//www.DrugPatentWatch.com/p/preview/generic-api/posaconazole?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Posaconazole is the ge…

Continue reading
Biotechblog